What’s new in the treatment for aggressive cervical cancer? Is there any new medicine for the disease?
In an article released by the U.S. National Cancer Institute (NCI), Dr. Krishnansu Tewari said that a new discovery might change the way women with cervical cancer were treated and could improve outcomes for patients. What he referred to is Avastin that probably can help increase the survival rate of women with aggressive cervical cancer.
Dr. Krishnansu Tewari was the lead researcher in the study involving 452 women with aggressive cervical cancer that cannot be cured by chemotherapy. When they were treated with Avastin, their lives were extended to an average of 17 months compared with 13 months for the patients treated with chemotherapy alone.
However, patients receiving Avastin had more side effects than ordinary chemotherapy. Therefore, further studies are necessary to improve this drug.
Keywords: aggressive cervical cancer